#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI0TUe
New review recommends second breast-conserving treatment as a personalized alternative in breast tumor recurrence.
🔓 OPEN ACCESS
➡️ https://t.co/MQwLxN91FK
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI1rJM
Research shows that tumor-stroma ratio and magnetic resonance imaging may be used to predict patient response to neoadjuvant endocrine therapy in hormone receptor-positive #BreastCancer.
🔓➡️ https://t.co/OzUjlI2JSt
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI0TUe
New research shows that the protective effect of an early first pregnancy does not attenuate the risk associated with weight gain of postmenopausal #BreastCancer.
🔓 OPEN ACCESS
➡️ https://t.co/VEFULXAe5F
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI1rJM
Modest effects are observed between levels of cell-division markers and aging markers, with poorer survival and better outcomes, respectively.
🔓 OPEN ACCESS
➡️ https://t.co/FlXxyUYypZ
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI0TUe
New study suggests that progesterone receptor (PR) heterogeneity in premenopausal patients increases long-term recurrence risk but benefits from endocrine therapy.
🔓 OPEN ACCESS
➡️ https://t.co/5khYqUDRph
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI0TUe
New review discusses role of Oncotype DX assay in personalized treatment in #BreastCancer, and future directions for integrating this tool in precision oncology.
👍FREE to read until 31.10!
➡️ https://t.co/iiQWsDrLND
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI0TUe
A novel, nickel filtration membrane facilitates rapid enrichment of circulating tumor cells (CTCs) from blood, with a superior ability to process high-volume #BreastCancer samples.
🔓➡️ https://t.co/TB62OI49Ja
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI1rJM
Decision aids (DAs), evidence-based tools to inform patients of their options, are valuable in decision-making for postmastectomy breast reconstruction (PMBR).
👍FREE to read until 31.10!
➡️ https://t.co/HiESVNedDb
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI1rJM
New review highlights the role of innate immune cells in an immunosuppressive tumor microenvironment in #BreastCancer with STAT3 as a central player.
👍FREE to read until 31.10!
➡️ https://t.co/ODNPadx28I
@uicc
#BCAM2026 Virtual Issue| 📌 https://t.co/eOsKpI1rJM
New research shows that persistent weight gain is associated with increased risk of #BreastCancer & uterine cancer in postmenopausal women and never-smokers.
🔓 OPEN ACCESS
➡️ https://t.co/ejp1o6wMy9
@uicc
📰 #TrendingResearchTuesday: Drinking very hot beverages could triple a person’s risk of getting #cancer in their esophagus, a large study finds.
@CNN covers the study: https://t.co/5o3dA1YRQN
The study is published in the International Journal of Cancer (@IntJCanc)
@uicc
#ComingSoon!
The newest #BreastCancerAwarenessMonth virtual issue from IJC with translational and clinical research articles.
➡️https://t.co/eOsKpI0TUe
All papers are FREE to read until the end of October!
NOW ONLINE!
This new review summarizes the changes between the 8th and 9th edition of the Tumour Node Metastases (TNM) classification as defined by the @uicc TNM committee, with a focus on head and neck and lung cancers.
🔓 OPEN ACCESS
➡️ https://t.co/VpRaxqI4S2
It’s #InternationalWomensDay2026
New findings show #BreatCancer survivors’ quality of life is lowest in the first six months after diagnosis but improves over time due to better awareness, education and treatment access #GiveToGain
🔓➡️ https://t.co/alB7WpzJEi
@uicc@womensday
The International Journal of Cancer is 60 years old 🎉
We are launching a virtual issue to celebrate the 60th anniversary, compiling seminal papers published in the journal through the years:
https://t.co/uv9ARfCZwl
FREE TO READ till the end of the year!
#HappyBirthdayIJC
It’s #RareDiseaseDay!
Genetic and epigenetic risk scores, especially when combined, can significantly improve early detection and personalized risk assessment for pleural mesothelioma in people exposed to asbestos
🔓➡️ https://t.co/R94W1G1TNA
@uicc@rarediseaseday
NOW ONLINE!
Check out the #Editorial from @IntJCanc 's very own Associate Editor, Prof. Hinrich Gronemeyer, on counteracting the delegitimization of science requires through accuracy, reproducibility, appropriate controls, and meaningful validation
🔓➡️ https://t.co/5i0dBCL1aH
#WorldCancerDay | 📌 Virtual issue https://t.co/aysI7Gif6R
Eloquent brain tumors pose surgical challenges, and this study shows that patient-centered measures of are key for long-term quality of life evaluations
🔓OPEN ACCESS
➡️ https://t.co/zfsV64t419
@uicc#UnitedByUnique